Skip to main content

Cearnal Martin E's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055478
Filed
Sep 10, 2021
Trade date
Aug 2-31, 2021
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $6.57K. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cearnal Martin ECIK 0001408500Director, Officer (Sr VP/Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Common StockPPurchaseAcquired+105$3.34+$350.7167,364Direct
Aug 3, 2021Common StockPPurchaseAcquired+105$3.17+$332.85167,469Direct
Aug 4, 2021Common StockPPurchaseAcquired+105$3.18+$333.9167,574Direct
Aug 5, 2021Common StockPPurchaseAcquired+105$3.11+$326.55167,679Direct
Aug 6, 2021Common StockPPurchaseAcquired+105$3.01+$316.05167,784Direct
Aug 9, 2021Common StockPPurchaseAcquired+105$2.93+$307.65167,889Direct
Aug 10, 2021Common StockPPurchaseAcquired+105$2.96+$310.8167,994Direct
Aug 11, 2021Common StockPPurchaseAcquired+105$2.98+$312.9168,099Direct
Aug 13, 2021Common StockPPurchaseAcquired+105$2.92+$306.6168,204Direct
Aug 16, 2021Common StockPPurchaseAcquired+105$2.92+$306.6168,309Direct
Aug 17, 2021Common StockPPurchaseAcquired+105$3.05+$320.25168,414Direct
Aug 18, 2021Common StockPPurchaseAcquired+105$2.97+$311.85168,519Direct
Aug 19, 2021Common StockPPurchaseAcquired+105$3.02+$317.1168,624Direct
Aug 20, 2021Common StockPPurchaseAcquired+105$2.96+$310.8168,729Direct
Aug 23, 2021Common StockPPurchaseAcquired+105$2.87+$301.35168,834Direct
Aug 24, 2021Common StockPPurchaseAcquired+105$2.89+$303.45168,939Direct
Aug 25, 2021Common StockPPurchaseAcquired+105$2.79+$292.95169,044Direct
Aug 26, 2021Common StockPPurchaseAcquired+105$2.82+$296.1169,149Direct
Aug 27, 2021Common StockPPurchaseAcquired+105$2.84+$298.2169,254Direct
Aug 30, 2021Common StockPPurchaseAcquired+105$2.88+$302.4169,359Direct
Aug 31, 2021Common StockPPurchaseAcquired+105$2.93+$307.65169,464Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)